Alpenglow Biosciences logo

Alpenglow Biosciences

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$1M


Alpenglow Biosciences develops a 3D spatial pathology platform that integrates imaging and AI to improve predictive diagnostics and intraoperative care, particularly in cancer treatment.

Total Funding

$1M

Headquarters

Seattle, USA

Founded

2018

Focus Areas

3D imaging
AI
pathology
tumor removal
cancer diagnostics
intraoperative care

Investors

Dynamk Capital logo